Regulation of Type II Luteinizing Hormone-Releasing Hormone (LHRH-II) Gene Expression by the Processed Peptide of LHRH-I,LHRH-(1–5) in Endometrial Cells
Restricted accessOtherFirst published online January, 2007
Regulation of Type II Luteinizing Hormone-Releasing Hormone (LHRH-II) Gene Expression by the Processed Peptide of LHRH-I,LHRH-(1–5) in Endometrial Cells
Luteinizing hormone-releasing hormone (LHRH) was first isolated in the mammalian hypothalamus and shown to be the primary regulator of the reproductive system through its initiation of pituitary gonadotropin release. Since its discovery, this form of LHRH (LHRH-I) has been shown to be one of many structural variants with a variety of roles in both the brain and peripheral tissues. Enormous interest has been focused on LHRH-I, LHRH-II, and their cognate receptors as targets for designing therapies to treat cancers of the reproductive system. LHRH-I is processed by a zinc metalloendopeptidase EC 3.4.24.15 (EP24.15) that cleaves the hormone at the Tyr5-Gly6 bond. We have previously reported that the autoregulation of LHRH gene expression can also be mediated by its processed peptide, LHRH-(1–5). Given its importance in the brain, we have investigated the role of the specific processed peptide of LHRH-I, LHRH-(1–5), within Ishikawa cells, a human endometrial cell line. Using real-time polymerase chain reaction, we observed that LHRH-(1–5) upregulates LHRH-II mRNA expression in Ishikawa cells but does not exert any influence on LHRH-I mRNA levels. This is in contrast to the effects of LHRH-I, which affects the expression of LHRH-I mRNA. Our findings support a potential role for LHRH-(1–5) as a processed metabolite in the endometrium. Further investigations are needed to determine the role of this processed metabolite and to identify specific pathways involved in LHRH-(1–5) signaling.
Get full access to this article
View all access options for this article.
References
1.
Sealfon SC, Weinstein H, Millar RP. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev18:180–205, 1997.
2.
Sherwood NM, Lovejoy DA, Coe IR. Origin of mammalian gonadotropin-releasing hormones. Endocr Rev14:241–254, 1993.
3.
Pawson AJ, Morgan K, Maudsley SR, Millar RP. Type II gonadotrophin-releasing hormone (GnRH-II) in reproductive biology. Reproduction126:271–278, 2003.
4.
Millar RP. GnRH II and type II GnRH receptors. Trends Endocrinol Metab14:35–43, 2003.
5.
Gestrin ED, White RB, Fernald RD. Second form of gonadotropin-releasing hormone in mouse: immunocytochemistry reveals hippocampal and periventricular distribution. FEBS Lett448:289–291, 1999.
6.
Chen A, Yahalom D, Ben-Aroya N, Kaganovsky E, Okon E, Koch Y. A second isoform of gonadotropin-releasing hormone is present in the brain of human and rodents. FEBS Lett435:199–203, 1998.
7.
Chen A, Yahalom D, Laskar-Levy O, Rahimipour S, Ben-Aroya N, Koch Y. Two isoforms of gonadotropin-releasing hormone are coexpressed in neuronal cell lines. Endocrinology142:830–837, 2001.
8.
Millar R, Lowe S, Conklin D, Pawson A, Maudsley S, Troskie B, Ott T, Millar M, Lincoln G, Sellar R, Faurholm B, Scobie G, Kuestner R, Terasawa E, Katz A. A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proc Natl Acad Sci U S A98:9636–9641, 2001.
9.
Clayton RN, Catt KJ. Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocr Rev2:186–209, 1981.
10.
Adelman JP, Mason AJ, Hayflick JS, Seeburg PH. Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. Proc Natl Acad Sci U S A83:179–183, 1986.
11.
Limonta P, Moretti RM, Marelli MM, Motta M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol24:279–295, 2003.
12.
Oikawa M, Dargan C, Ny T, Hsueh AJ. Expression of gonadotropin-releasing hormone and prothymosin-alpha messenger ribonucleic acid in the ovary. Endocrinology127:2350–2356, 1990.
13.
Palmon A, Ben Aroya N, Tel-Or S, Burstein Y, Fridkin M, Koch Y. The gene for the neuropeptide gonadotropin-releasing hormone is expressed in the mammary gland of lactating rats. Proc Natl Acad Sci U S A91:4994–4996, 1994.
14.
White RB, Eisen JA, Kasten TL, Fernald RD. Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci U S A95:305–309, 1998.
15.
Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E, Koch Y. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res62:1036–1044, 2002.
16.
Cheon KW, Lee HS, Parhar IS, Kang IS. Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod7:447–452, 2001.
17.
Choi KC, Auersperg N, Leung PC. Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. J Clin Endocrinol Metab86:5075–5078, 2001.
18.
Molineaux CJ, Lasdun A, Michaud C, Orlowski M. Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo. J Neurochem51:624–633, 1988.
19.
Wu TJ, Pierotti AR, Jakubowski M, Sheward WJ, Glucksman MJ, Smith AI, King JC, Fink G, Roberts JL. Endopeptidase EC 3.4.24.15 presence in the rat median eminence and hypophysial portal blood and its modulation of the luteinizing hormone surge. J Neuroendocrinol9: 813–822, 1997.
20.
Wu TJ, Mani SK, Glucksman MJ, Roberts JL. Stimulation of luteinizing hormone-releasing hormone (LHRH) gene expression in GT1–7 cells by its metabolite, LHRH-(1–5). Endocrinology146:280–286, 2005.
21.
Wu TJ, Glucksman MJ, Roberts JL, Mani SK. Facilitation of lordosis in rats by a metabolite of luteinizing hormone releasing hormone (LHRH). Endocrinology147:2544–2549, 2006.
22.
Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Holzel F, Schulz KD, Schally AV. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res53:5439–5446, 1993.
23.
Grundker C, Volker P, Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase. Endocrinology142:2369–2380, 2001.
24.
Volker P, Grundker C, Schmidt O, Schulz KD, Emons G. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. Am J Obstet Gynecol186:171–179, 2002.
25.
Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K. [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. Nippon Sanka Fujinka Gakkai Zasshi37:1103–1111, 1985.
26.
Grundker C, Gunthert AR, Millar RP, Emons G. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab87:1427–1430, 2002.
27.
Kang SK, Choi KC, Cheng KW, Nathwani PS, Auersperg N, Leung PC. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium. Endocrinology141:72–80, 2000.
28.
Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol132:365–386, 2000.
29.
Terasawa E, Busser BW, Luchansky LL, Sherwood NM, Jennes L, Millar RP, Glucksman MJ, Roberts JL. Presence of luteinizing hormone-releasing hormone fragments in the rhesus monkey forebrain. J Comp Neurol439:491–504, 2001.
30.
Rissman EF, Alones VE, Craig-Veit CB, Millam JR. Regulation of chicken-II gonadotropin-releasing hormone in mammalian brain. J Comp Neurol357:524–531, 1995.
31.
Glucksman MJ, Roberts JL. Strategies for characterizing cloning and expressing soluble endopeptidases. In: Smith AI, Ed. Peptidases and Neuropeptide Processing. San Diego: Academic Press, pp296–316, 1995.
32.
Golla R, Seethala R. A homogeneous enzyme fragment complementation cyclic AMP screen for GPRCR agonists. J Biomolecular Screen7: 515–525, 2002.
33.
Schneider F, Tomek W, Grundker C. Gonadotropin-releasing hormone (GnRH) and its natural analogues: a review. Theriogenology April 28 ePub.
34.
Krsmanovic LZ, Stojilkovic SS, Mertz LM, Tomic M, Catt KJ. Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons. Proc Natl Acad Sci U S A90:3908–3912, 1993.
35.
Krsmanovic LZ, Martinez-Fuentes AJ, Arora KK, Mores N, Navarro CE, Chen HC, Stojilkovic SS, Catt KJ. Autocrine regulation of gonadotropin-releasing hormone secretion in cultured hypothalamic neurons. Endocrinology140:1423–1431, 1999.
36.
Han YG, Kang SS, Seong JY, Geum D, Suh YH, Kim K. Negative regulation of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression by a gonadotrophin-releasing hormone agonist in the rat hypothalamus. J Neuroendocrinol11:195–201, 1999.
37.
DePaolo LV, King RA, Carrillo AJ. In vivo and in vitro examination of an autoregulatory mechanism for luteinizing hormone-releasing hormone. Endocrinology120:272–279, 1987.
38.
Roth C, Schricker M, Lakomek M, Strege A, Heiden I, Luft H, Munzel U, Wuttke W, Jarry H. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. J Endocrinol169:361–371, 2001.
39.
Bourguignon JP, Alvarez Gonzalez ML, Gerard A, Franchimont P. Gonadotropin releasing hormone inhibitory autofeedback by sub-products antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion. Endocrinology134:1589–1592, 1994.
40.
Orlowski M, Michaud C, Chu TG. A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides. Eur J Biochem135:81–88, 1983.
41.
Lew RA, Tetaz TJ, Glucksman MJ, Roberts JL, Smith AI. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts. J Biol Chem269:12626–12632, 1994.
42.
Dudley CA, Lee Y, Moss RL. Electrophysiological identification of a pathway from the septal area to the medial amygdala: sensitivity to estrogen and luteinizing hormone releasing hormone. Synapse6:161–168, 1990.
43.
Jennes L, Dines H, Dalati B. Development and specificity of gonadotropin-releasing hormone (GnRH) receptors in rat brain. Soc Neurosci Abstract14:10, 1988.
44.
Dudley CA, Moss RL. Facilitation of sexual receptivity in the female rat by C-terminal fragments of LHRH. Physiol Behav50:1205–1208, 1991.
45.
Chen Y, Wong M, Moss RL. Effects of a biologically active LHRH fragment on CA1 hippocampal neurons. Peptides14:1079–1081, 1993.
46.
Limonta P, Moretti RM, Marelli MM, Dondi D, Parenti M, Motta M. The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, signal transduction pathway. Endocrinology140:5250–5256, 1999.
47.
Hsieh KP, Martin TFJ. Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptor activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Mol Endocrinol6:1673–1681, 1992.
48.
Stojilkovic SS, Catt KJ. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog Horm Res50:161–205, 1995.
49.
Naor Z, Harris D, Shaccam D. Mechanism of GnRH receptor signaling: combinatorial cross-talk of Ca2+ and protein kinase C. Front Neuroendocrinol19:1–19, 1998.
50.
Kauffman AS, Rissman EF. A critical role for the evolutionarily conserved gonadotropin-releasing hormone II: mediation of energy status and female sexual behavior. Endocrinology145:3639–3646, 2004.
51.
Montaner AD, Affanni JM, King JA, Bianchini JJ, Tonarelli G, Somoza GM. Differential distribution of gonadotropin-releasing hormone variants in the brain of Hydrochaeris hydrochaeris (Mammalia, Rodentia). Cell Mol Neurobiol19:635–651, 1999.
52.
Morgan K, Conklin D, Pawson AJ, Sellar R, Ott TR, Millar RP. A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology144:423–436, 2003.
53.
Ling K, Wang P, Zhao J, Wu YL, Cheng ZJ, Wu GX, Hu W, Ma L, Pei G. Five-transmembrane domains appear sufficient for a G protein-coupled receptor: functional five-transmembrane domain chemokine receptors. Proc Natl Acad Sci U S A96:7922–7927, 1999.
54.
Pawson AJ, Maudsley S, Morgan K, Davidson L, Naor Z, Millar RP. Inhibition of human type I gonadotropin-releasing hormone receptor (GnRHR-I) function by expression of a human type II GnRHR gene fragment. Endocrinology146:2639–2649, 2005.
55.
Grosse R, Schoneberg T, Schultz G, Gudermann T. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol Endocrinol11:1305–1318, 1997.
56.
Lu ZL, Gallagher R, Sellar R, Coetsee M, Millar RR. Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor binding sites specifically increase binding affinity for GnRH II, but not GnRH I: Evidence for ligand-selective receptor active conformations. J Biol Chem2005.
57.
Caunt CJ, Hislop JN, Kelly E, Matharu AL, Green LD, Sedgley KR, Finch AR, McArdle CA. Regulation of gonadotropin-releasing hormone receptors by protein kinase C: inside out signalling and evidence for multiple active conformations. Endocrinology145:3594–3602, 2004.
58.
Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. Gonadotropin-releasing hormone receptors. Endocr Rev25:235–275, 2004.
59.
Grundker C, Gunthert AR, Westphalen S, Emons G. Biology of the gonadotropin-releasing hormone system in gynecological cancers. Eur J Endocrinol146:1–14, 2002.
60.
Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol55: 144–148, 1994.
61.
Imai A, Takagi H, Horibe S, Fuseya T, Tamaya T. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab81:3249–3253, 1996.
62.
Emons G, Muller V, Ortmann O, Schulz KD. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol65:199–206, 1998.
63.
Emons G, Ortmann O, Schulz KD, Schally AV. Growth-inhibitory actions of analogs of luteinizing hormone releasing hormone on tumor cells. Trends Endocrinol Metab8:155–362, 1997.
